Search Results - "SMIDT, U. M"

Progression of diabetic nephropathy by Hovind, Peter, Rossing, Peter, Tarnow, Lise, Smidt, Ulla M., Parving, Hans-Henrik

“…Progression of diabetic nephropathy. Diabetic nephropathy is a major cause of renal failure. The decline in glomerular filtration rate (GFR) is highly…”
Get full text

Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment by ROSSING, P, HOMMEL, E, SMIDT, U. M, PARVING, H.-H

“…Diabetic nephropathy is the main cause of increased mortality and morbidity in IDDM patients. The effect of antihypertensive treatment on the progression of…”
Get full text

Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively by HOVIND, Peter, ROSSING, Peter, TARNOW, Lise, SMIDT, Ulla M, PARVING, Hans-Henrik

“…Diabetic nephropathy is a chronic, progressive kidney disease with a mean rate of decline of in glomerular filtration rate (GFR) of 10 to 12 mL/min/year…”
Get full text

Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy by Nielsen, F. S., Rossing, P., Gall, M. A., Skott, P., Smidt, U. M., Parving, H. H.

“…Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. F S Nielsen , P Rossing , M A Gall , P…”
Get full text

Increased sympathetic activity during sleep and nocturnal hypertension in Type 2 diabetic patients with diabetic nephropathy by Nielsen, F. S., Hansen, H. P., Jacobsen, P., Rossing, P., Smidt, U. M., Christensen, N. J., Pevet, P., Vivien-Roels, B., Parving, H. -H.

“…Summary Aims To elucidate the putative factors involved in the blunted nocturnal blood pressure reduction in hypertensive Type 2 diabetic patients with…”
Get full text

The course of kidney function in Type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy by GALL, M.-A, NIELSEN, F. S, SMIDT, U. M, PARVING, H.-H

“…We evaluated the impact of some putative progression promoters on kidney function in albuminuric Type 2 (non-insulin-dependent) diabetic patients with…”
Get full text

Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy by PARVING, H.-H, NIELSEN, F. S, BANG, L. E, SMIDT, U. M, SVENDSEN, T. L, CHEN, J.-W, GALL, M.-A, ROSSING, P

“…The Steno hypothesis suggests that albuminuria reflects widespread vascular damage (proliferative retinopathy and severe macroangiopathy) due to a generalized…”
Get full text

Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy by Parving, H. H., Hommel, E., Smidt, U. M.

“…STUDY OBJECTIVE--To assess whether long term inhibition of angiotensin converting enzyme with captopril and frusemide or bendrofluazide protects kidney…”
Get full text

Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients by Rossing, P., Hommel, E., Smidt, U. M., Parving, H. H.

“…Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. P Rossing , E Hommel , U M Smidt and H H Parving…”
Get full text

Reduction in albuminuria predicts diminished progression in diabetic nephropathy by Rossing, P, Hommel, E, Smidt, U M, Parving, H H

“…We have evaluated putative predictors of the progression in diabetic nephropathy during long-term antihypertensive treatment. Twenty hypertensive…”
Get more information

On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy by Nielsen, F. S., Rossing, P., Bang, L. E., Svendsen, T. L., Gall, M. A., Smidt, U. M., Parving, H. H.

“…On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy. F S Nielsen , P Rossing , L E Bang , T L…”
Get full text

Benefits of long-term antihypertensive treatment on prognosis in diabetic nephropathy by Parving, Hans-Henrik, Jacobsen, Peter, Rossing, Kasper, Smidt, Ulla M., Hommel, Eva, Rossing, Peter

“…Benefits of long-term antihypertensive treatment on prognosis in diabetic nephropathy. We assessed the prognosis of diabetic nephropathy during long-term…”
Get full text

Left Ventricular Hypertrophy in Non-insulin-dependent Diabetic Patients With and Without Diabetic Nephropathy by Nielsen, F.S, Ali, S., Rossing, P., Bang, L.E., Svendsen, T.L., Gall, M.-A., Smidt, U.M., Kastrup, J., Parving, H.-H.

“…The aim of our cross‐sectional case–control study was to evaluate putative mechanisms of the increased cardiac morbidity and mortality in NIDDM patients with…”
Get full text

Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathy by Parving, H H, Smidt, U M, Hommel, E, Mathiesen, E R, Rossing, P, Nielsen, F, Gall, M A

“…The effect of long-term, aggressive, antihypertensive treatment on kidney function in diabetic nephropathy was studied prospectively in 11 insulin-dependent…”
Get more information

Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy by Nielsen, F. S., Rossing, P., Gall, M. A., Skott, P., Smidt, U. M., Parving, H. H.

“…Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. F S Nielsen , P Rossing , M A Gall , P Skøtt , U…”
Get full text

Monitoring kidney function in diabetic nephropathy by ROSSING, P, ASTRUP, A.-S, SMIDT, U. M, PARVING, H.-H

“…Progression in diabetic nephropathy is usually determined by repeated measurements of glomerular filtration rate and expressed as rate of decline in glomerular…”
Get full text

Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial by Lund, S.S, Tarnow, L, Stehouwer, C.D.A, Schalkwijk, C.G, Frandsen, M, Smidt, U.M, Pedersen, O, Parving, H.-H, Vaag, A

“…Metformin is the 'drug-of-first-choice' in obese patients with type 2 diabetes mellitus (T2DM) due to its antihyperglycaemic and cardiovascular protective…”
Get full text

Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy by NIELSEN, F. S, ROSSING, P, GALL, M.-A, SKØTT, P, SMIDT, U. M, PARVING, H.-H

“…The aim of our study was to evaluate whether inhibition of ACE (lisinopril 10-20 mg/day) can reduce the rate of decline in kidney function more than reducing…”
Get full text

Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy by Nielsen, F. S., Rossing, P., Gall, M. A., Smidt, U. M., Chen, J. W., Sato, A., Parving, H. H.

“…Endothelial dysfunction is a prevalent phenomenon in non-insulin dependent diabetic (NIDDM) patients with hypertension and albuminuria, and may contribute to…”
Get full text

Assessment of glomerular filtration rate in diabetic nephropathy using the plasma clearance of 51Cr-EDTA by Hansen, H. P., Rossing, P., Mathiesen, E. R., Hommel, E. E, Smidt, U. M., Parving, H.-H.

“…Plasma clearance of 51Cr-EDTA is widely used to assess the glomerular filtration rate (GFR) in diabetic nephropathy. Originally, the ratio between the…”
Get full text